SCHEMBL3784050

SCHEMBL3784050

Nc1ccc(C2CCCC2)c(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.46
TSHR P16473 3/20 0.46
ALDH1A1 P00352 4/20 0.43
POLB P06746 1/20 0.43
HTT P42858 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CEL P19835 2/20 0.42
SIGMAR1 Q99720 2/20 0.40
TMEM97 Q5BJF2 1/20 0.40
EBP Q15125 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
CHRNB2 P17787 1/20 0.39
CHRNA4 P43681 1/20 0.39
GAA P10253 2/20 0.39
AGTR1 P30556 1/20 0.39
MAPT P10636 2/20 0.38
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3792360 0.98 ALDH1A1 (0.46) CYP3A4TSHRALDH1A1POLBHTT
SCHEMBL3786596 0.96 CYP3A4 (0.46) CYP3A4TSHRALDH1A1POLBHTT
SCHEMBL29769051 0.92 CYP3A4 (0.50) CYP3A4TSHRALDH1A1POLBHTT
SCHEMBL3786523 0.92 CYP3A4 (0.50) CYP3A4TSHRALDH1A1POLBHTT
SCHEMBL3785645 0.84 CYP3A4 (0.46) CYP3A4TSHRALDH1A1POLBHTT
SCHEMBL4966136 0.83 CHRNB2 (0.43) CYP3A4TSHRALDH1A1HTTCA1
SCHEMBL3781669 0.82 CYP3A4 (0.45) CYP3A4TSHRALDH1A1POLBHTT
SCHEMBL12073521 0.80 HTR1D (0.55) CYP3A4TSHRALDH1A1POLBHTT
SCHEMBL3786817 0.80 CYP3A4 (0.46) CYP3A4TSHRALDH1A1POLBHTT
SCHEMBL432639 0.79 GAA (0.58) TSHRCELGAAAGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 CYP3A4 177/4885TSHR 1688/4885ALDH1A1 4339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.